Pharmaceutical Executive
A look at how Europe's new accelerated drug approval scheme can evolve existing review pathways for the better-and take a page from FDA
Anusha Bala
Advertisement
Articles by Anusha Bala
Advertisement
Latest Updated Articles
'PRIME' Time for Medicines in the EUJuly 12th 2016
Advertisement
Advertisement
Trending on PharmExec
1
FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy
2
FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B
3
Roundup: Alcon Acquires Neurotech and Encelto, Ai Proteins Enters Research Collaboration and License Agreement with Astellas Pharma
4
Pharmaceutical Executive Daily: FDA Grants Ultomiris Accelerated Approval in the U.S.
5